anti-CDH17/GUCY2C dual-payload bispecific antibody-drug conjugate (Hangzhou Dac Biotech)

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug Nameanti-CDH17/GUCY2C dual-payload bispecific antibody-drug conjugate (Hangzhou Dac Biotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Cadherin-17Anti-Heat-stable enterotoxin receptor
TargetsCadherin-17Heat-stable enterotoxin receptor
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Dac Biotech Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Dac Biotech Company Ltd
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A